Logan Capital Management’s Biogen BIIB Stock Holding History

Logan Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-115	Closed	-$32K	–	489
2023 Q1	$32K	Hold	115	–	–	﹤0.01%	367
2022 Q4	$31.8K	Hold	115	–	–	﹤0.01%	374
2022 Q3	$31K	Hold	115	–	–	﹤0.01%	366
2022 Q2	$23K	Hold	115	–	–	﹤0.01%	390
2022 Q1	$24K	Hold	115	–	–	﹤0.01%	396
2021 Q4	$28K	Hold	115	–	–	﹤0.01%	405
2021 Q3	$33K	Hold	115	–	–	﹤0.01%	389
2021 Q2	$40K	Hold	115	–	–	﹤0.01%	365
2021 Q1	$32K	Buy	+115	New	+$31K	﹤0.01%	373
2017 Q1	–	Sell	-738	Closed	-$209K	–	268
2016 Q4	$209K	Buy	+738	New	+$219K	0.02%	272
2015 Q4	–	Sell	-11,977	Closed	-$3.5M	–	286
2015 Q3	$3.5M	Buy	11,977 +102	+0.9%	+$33.7K	0.29%	85
2015 Q2	$4.8M	Sell	11,875 -416	-3%	-$167K	0.35%	77
2015 Q1	$5.19M	Buy	12,291 +88	+0.7%	+$34.7K	0.37%	75
2014 Q4	$4.14M	Sell	12,203 -1,932	-14%	-$625K	0.3%	82
2014 Q3	$4.68M	Buy	14,135 +152	+1%	+$50.1K	0.34%	77
2014 Q2	$4.41M	Buy	+13,983	New	+$4.21M	0.31%	80

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Logan Capital Management's BIIB Position: Q2 2023 in Review

Logan Capital Management sold out of Biogen (BIIB) in Q2 2023, closing a stake of 115 shares — an estimated $32K sold.

Logan Capital Management first reported a position in BIIB in Q2 2014 and held it in 16 quarters. The position peaked at $5.19M in Q1 2015. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

Logan Capital Management reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
Logan Capital Management sold 115 Biogen shares in Q2 2023, an estimated $32K.
Logan Capital Management first reported a position in Biogen in Q2 2014 and held it in 16 quarters.
Logan Capital Management's Biogen position peaked at $5.19M in Q1 2015.
1,009 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Logan Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.